I understand your concerns but I contend you should think more laterally. The potential buyout is of the drug, Bisantrene. If our compound is proven (and it is in many ways) US pharma will buy it because it will make them millions and millions. They don't care that it is Australian. Think of it this way. Generally, Australian basketball is not respected by the NBA but Andrew Bogut was the number 1 NBA draft pick in 2005. They didn't care that he was Australian. They were only interested in what he could bring to the court. Cheers. Onward.
Prediction - RAC will have legendary unicorn-like status among drug-development biotechs?, page-24
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.050(3.33%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $86.32K | 57.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4520 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 2259 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |